Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.
Source | Last Updated |
---|---|
Alliance of Genome Resources | July 29, 2024 |
Disease ID | Disease Name | Alliance of Genome Resources ID ▼ | Species | Gene ID | Gene Symbol | FlyGlycoDB | Evidence Code Names | References |
---|---|---|---|---|---|---|---|---|
DOID:6432 | pulmonary hypertension | ZFIN:ZDB-GENE-020828-1 | Danio rerio (zebrafish) | 260350 | has2 |
|
||
DOID:3525 | middle cerebral artery infarction | ZFIN:ZDB-GENE-020828-1 | Danio rerio (zebrafish) | 260350 | has2 |
|
||
DOID:0080575 | Larsen-like syndrome B3GAT3 type | ZFIN:ZDB-GENE-020419-3 | Danio rerio (zebrafish) | 192334 | b3gat3 |
|
||
DOID:2978 | carbohydrate metabolic disorder | ZFIN:ZDB-GENE-020416-4 | Danio rerio (zebrafish) | 560753 | tpi1b |
|
||
DOID:1289 | neurodegenerative disease | ZFIN:ZDB-GENE-020416-4 | Danio rerio (zebrafish) | 560753 | tpi1b |
|
||
DOID:162 | cancer | ZFIN:ZDB-GENE-020416-4 | Danio rerio (zebrafish) | 560753 | tpi1b |
|
||
DOID:0050884 | triosephosphate isomerase deficiency | ZFIN:ZDB-GENE-020416-4 | Danio rerio (zebrafish) | 560753 | tpi1b |
|
||
DOID:9282 | ocular hypertension | ZFIN:ZDB-GENE-020416-4 | Danio rerio (zebrafish) | 560753 | tpi1b |
|
||
DOID:162 | cancer | ZFIN:ZDB-GENE-020416-3 | Danio rerio (zebrafish) | 192309 | tpi1a |
|
||
DOID:9282 | ocular hypertension | ZFIN:ZDB-GENE-020416-3 | Danio rerio (zebrafish) | 192309 | tpi1a |
|
||
DOID:1289 | neurodegenerative disease | ZFIN:ZDB-GENE-020416-3 | Danio rerio (zebrafish) | 192309 | tpi1a |
|
||
DOID:0050884 | triosephosphate isomerase deficiency | ZFIN:ZDB-GENE-020416-3 | Danio rerio (zebrafish) | 192309 | tpi1a |
|
||
DOID:2978 | carbohydrate metabolic disorder | ZFIN:ZDB-GENE-020416-3 | Danio rerio (zebrafish) | 192309 | tpi1a |
|
||
DOID:9744 | type 1 diabetes mellitus | Xenbase:XB-GENE-998849 | Xenopus tropicalis (tropical clawed frog) | 100489505 | ugt1a1 |
|
||
DOID:2043 | hepatitis B | Xenbase:XB-GENE-998849 | Xenopus tropicalis (tropical clawed frog) | 100489505 | ugt1a1 |
|
||
DOID:8778 | Crohn's disease | Xenbase:XB-GENE-998849 | Xenopus tropicalis (tropical clawed frog) | 100489505 | ugt1a1 |
|
||
DOID:3908 | lung non-small cell carcinoma | Xenbase:XB-GENE-998849 | Xenopus tropicalis (tropical clawed frog) | 100489505 | ugt1a1 |
|
||
DOID:2741 | bilirubin metabolic disorder | Xenbase:XB-GENE-998849 | Xenopus tropicalis (tropical clawed frog) | 100489505 | ugt1a1 |
|
||
DOID:9352 | type 2 diabetes mellitus | Xenbase:XB-GENE-998849 | Xenopus tropicalis (tropical clawed frog) | 100489505 | ugt1a1 |
|
||
DOID:1793 | pancreatic cancer | Xenbase:XB-GENE-998849 | Xenopus tropicalis (tropical clawed frog) | 100489505 | ugt1a1 |
|
||
DOID:1612 | breast cancer | Xenbase:XB-GENE-998849 | Xenopus tropicalis (tropical clawed frog) | 100489505 | ugt1a1 |
|
||
DOID:4988 | alcoholic pancreatitis | Xenbase:XB-GENE-998849 | Xenopus tropicalis (tropical clawed frog) | 100489505 | ugt1a1 |
|
||
DOID:4947 | cholangiocarcinoma | Xenbase:XB-GENE-998849 | Xenopus tropicalis (tropical clawed frog) | 100489505 | ugt1a1 |
|
||
DOID:7998 | hyperthyroidism | Xenbase:XB-GENE-998849 | Xenopus tropicalis (tropical clawed frog) | 100489505 | ugt1a1 |
|
||
DOID:1380 | endometrial cancer | Xenbase:XB-GENE-998849 | Xenopus tropicalis (tropical clawed frog) | 100489505 | ugt1a1 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024